Krishna Raghavan, MD
IV drug users: The new face of candidemia
April 28, 2021
Intravenous drug use is an increasingly common risk factor for candidemia as the opioid crisis worsens.
Thyroid hormone analogues can reverse NASH
April 27, 2021
In patients with nonalcoholic steatohepatitis (NASH) and stages 1-3 fibrosis, does the thyroid hormone receptor beta-agonist, resmetirom reduce hepatic steatosis compared with placebo?